There is only one Cardiolite®

Welcome to Cardiolite® (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), one of the world’s leading cardiac imaging agents.

For almost two decades, Cardiolite® has been used to image more than 40 million patients1, giving healthcare providers and the technologists across the U.S. the confidence to image many more.

Find out more about how Cardiolite® has helped physicians diagnose and manage patients with known or suspected coronary artery disease.

Click here to view our updated patient education video

Cardiolite Patient Education




Footnotes

1. The Imaging Market Guide (USA Edition 1992-2008), Arlington Medical Resources, Inc, Malvern PA, Confidential and Proprietary to AMR.


Lantheus Logo

Indications and Usage for Cardiolite®:
Cardiolite®, Kit for the Preparation of Technetium Tc99m Sestamibi for Injection, is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. Cardiolite® evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques (e.g., exercise or pharmacologic stress in accordance with the pharmacologic stress agent's labeling).

It is usually not possible to determine the age of a myocardial infarction or to differentiate a recent myocardial infarction from ischemia.

Important Safety Information for Cardiolite®:
Exercise and pharmacologic stress testing should be performed only under the supervision of a qualified physician. Cardiolite® has been rarely associated with acute severe allergic and anaphylactic events of angioedema and generalized urticaria. The most frequently reported adverse events include headache, chest pain/angina, ST segment changes on ECG, nausea, and abnormal taste and smell.

Download Prescribing Information PDF's:

Indications and Usage for Thallous Chloride TI-201 Injection:
Thallous Chloride Tl-201 Injection may be useful in myocardial perfusion imaging using either planar or SPECT (single photon computed tomography) techniques for the diagnosis and localization of myocardial infarction. It may also have prognostic value regarding survival, when used in the clinically stable patient following the onset of symptoms of an acute myocardial infarction, to assess the site and size of perfusion defect.

Thallous Chloride Tl-201 Injection may also be useful in conjunction with exercise stress testing as an adjunct in the diagnosis of ischemic heart disease (atherosclerotic coronary artery disease).

It is usually not possible to differentiate recent from old myocardial infarction, or to differentiate between recent myocardial infarction and ischemia.

Important Safety Information for Thallous Chloride TI-201 Injection:
Adverse patient reaction to Thallous Chloride Tl-201 Injection is extremely rare. Rashes and/or temporary low blood pressure have occurred, which have been treated with no further reported complications.